Approximately 39 million people in the U.S. have migraine and up to 1 million have cluster headache, Amneal noted. There are limited treatment options for cluster headache.

Learn about common-over-the-counter (OTC) treatments for migraine attacks, including acetaminophen and NSAIDs such as aspirin ...

When the pain in your head escalates from a dull discomfort to throbbing pain—especially when accompanied by nausea, tiredness, or sensitivity to lights or smells—there’s a good chance you’re ...

In adults with migraine and two-to-four previous preventive treatment failures, eptinezumab provided significant migraine preventive effects compared with placebo, with acceptable safety and ...

For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days, ...

A 75% plus increase in good days/month with eptinezumab is associated with improved migraine symptoms, brain fog, and overall well-being in chronic migraine.

An observational study examined ESKD risk among patients with migraine taking vs not taking topiramate. The migraine drug topiramate may provide kidney health benefits, according to research.

Atogepant 60 mg once daily leads to meaningful weight loss in patients with overweight or obesity receiving preventive migraine treatment.

STS101 nasal powder, DHE, delivers fast, lasting relief from cardinal migraine symptoms, including photophobia, phonophobia, and nausea.

mMR is associated with better treatment response than gepants in patients with migraine who previously had an inadequate response to gepants.

In 2018, the United States Food and Drug Administration (FDA) approved Aimovig (erenumab) for the prevention of migraine. Erenumab is the first FDA approved antibody therapeutic against a ...